10/16/2024 7:06 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 7:06 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 3:50 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 3:38 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 7:04 AM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 7:09 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 3:03 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/23/2024 5:00 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 8:19 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 3:34 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 4:14 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:16 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:10 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:11 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:13 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 8:09 AM | Akero Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/05/2024 3:05 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:08 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:30 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 10:11 AM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:32 PM | Akero Therapeutics (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 3:27 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 10:45 AM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2024 8:32 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 4:54 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:25 PM | Akero Therapeutics (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024 8:41 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:55 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:55 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:56 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:56 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:57 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:01 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:04 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:06 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:09 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:11 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:13 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 4:23 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
I've got news for you… (Ad) Today, I’m doing something I thought I’d never do…
Especially since I’m not normally a “swing for the fences” type of trader.
But I’ve been quietly testing a new type of trade for a while now…
And the returns are too good not to share with you.
Take a look…
I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman |
06/11/2024 4:20 PM | Akero Therapeutics (Issuer) Judy Chou (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:22 PM | Akero Therapeutics (Issuer) Harrison Seth Loring (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:24 PM | Akero Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:25 PM | Akero Therapeutics (Issuer) Heyman Tomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:28 PM | Akero Therapeutics (Issuer) Iwicki Mark T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:29 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:31 PM | Akero Therapeutics (Issuer) Xu Yuan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:17 PM | Akero Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
06/05/2024 4:05 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 6:17 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 8:07 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 6:32 PM | Akero Therapeutics (Issuer) Gangloff Scott A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/01/2024 6:36 PM | Akero Therapeutics (Issuer) Gangloff Scott A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:30 PM | Akero Therapeutics (Filer)
| Form PRE 14A | |
04/03/2024 5:55 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:17 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024 3:31 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:43 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:44 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:45 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 9:08 AM | Akero Therapeutics (Subject) GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024 7:13 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:14 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:25 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024 4:16 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:30 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 6:55 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 3:42 PM | Akero Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:19 PM | Akero Therapeutics (Subject) PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:06 AM | Akero Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024 8:40 PM | Akero Therapeutics (Subject) Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024 5:30 PM | Akero Therapeutics (Subject) ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 10:31 AM | Akero Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024 8:36 AM | Akero Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023 7:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:07 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 7:49 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:37 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:39 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:40 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:29 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 6:08 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Massive shakeup in defense contracting (Ad) There is a little-known energy technology stock that has made an incredible breakthrough…
Which could become crucial to the operations of the US Military.
And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska.
Now, this incredible breakthrough is still in its earliest stages…
Which means you still have a chance to get in while its trading for under $10. You need to check out the full story right here. |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:38 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:26 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 7:59 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 8:06 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 7:37 AM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:37 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |